Japanese stocks open at record highs as expectations of snap poll rise

Japanese stocks open at record highs as expectations of snap poll rise


Osanbashi in Yokohama on December 10, 2022.

Yuichi Yamazaki | Afp | Getty Images

Japanese indexes hit record highs Wednesday on expectations that Prime Minister Sanae Takaichi could call for a snap election, likely in February.

If called, it will be Takaichi’s first time facing Japan’s voters in an election.

The Nikkei 225 index rose as much as 1%, crossing the 54,000 mark for the first time, after gaining over 3% to hit a record high Tuesday. The Topix also continued to push fresh highs and gained 0.6%.

The Japanese yen has also weakened past the 159 mark against the dollar, reaching its lowest level since July 2024, when Japanese authorities intervened to stop the yen’s slide.

Other Asia markets mirrored losses on Wall Street overnight.

South Korea’s Kospi hovered above the flatline, while the small-cap Kosdaq was 0.37% lower.

Australia’s S&P/ASX 200 was flat.

Meanwhile, Hong Kong’s Hang Seng index futures were at 26,920, pointing to a stronger open compared to the HSI’s last close of 26,848.47.



Source

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
World

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift […]

Read More
The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector
World

The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector

This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and […]

Read More
Novartis shells out  billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
World

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]

Read More